Missing effects of zinc in a porcine model of recurrent endotoxemia

  • Carsten J Krones1Email author,

    Affiliated with

    • Bernd Klosterhalfen2,

      Affiliated with

      • Michael Anurov3,

        Affiliated with

        • Michael Stumpf1,

          Affiliated with

          • Uwe Klinge1,

            Affiliated with

            • Alexander P Oettinger3 and

              Affiliated with

              • Volker Schumpelick1

                Affiliated with

                BMC Surgery20055:22

                DOI: 10.1186/1471-2482-5-22

                Received: 17 May 2005

                Accepted: 20 October 2005

                Published: 20 October 2005



                Chronic human sepsis often is characterised by the compensatory anti-inflammatory response syndrome (CARS). During CARS, anti-inflammatory cytokines depress the inflammatory response leading to secondary and opportunistic infections. Proved in vitro as well as in vivo, zinc's pro-inflammatory effect might overcome this depression.


                We used the model of porcine LPS-induced endotoxemia established by Klosterhalfen et al. 10 pigs were divided into two groups (n = 5). Endotoxemia was induced by recurrent intravenous LPS-application (1.0 μg/kg E. coli WO 111:B4) at hours 0, 5, and 12. At hour 10, each group received an intravenous treatment (group I = saline, group II = 5.0 mg/kg elementary zinc). Monitoring included hemodynamics, blood gas analysis, and the thermal dilution technique for the measurement of extravascular lung water and intrapulmonary shunt. Plasma concentrations of IL-6 and TNF-alpha were measured by ELISA. Morphology included weight of the lungs, width of the alveolar septae, and rate of paracentral liver necrosis.


                Zinc's application only trended to partly improve the pulmonary function. Compared to saline, significant differences were very rare. IL-6 and TNF-alpha were predominately measured higher in the zinc group. Again, significance was only reached sporadically. Hemodynamics and morphology revealed no significant differences at all.


                The application of zinc in this model of recurrent endotoxemia is feasible and without harmful effects. However, a protection or restoration of clinical relevance is not evident in our setting. The pulmonary function just trends to improve, cytokine liberation is only partly activated, hemodynamics and morphology were not influenced. Further pre-clinical studies have to define zinc's role as a therapeutic tool during CARS.


                Although most patients survive the initial insult of a hyper-inflammatory sepsis syndrome, they remain at an increased risk of secondary or opportunistic infections. Basic course is the compensatory anti-inflammatory response syndrome (CARS) which derives from sustained or chronic stages of sepsis [1, 2]. During CARS, anti-inflammatory members of the cytokine network as IL-10, TGF-β, and IL-1RA depress the inflammatory response, thus reversing the effects of pro-inflammatory cytokines as TNFα, IL-1, and IL-6 [310]. Accompanied by a macrophage deactivation, a T-cell anergy, and an apoptotic loss of lymphoid tissues, the human clinical syndrome of CARS is characterised by uncontrolled infections followed by organ damages associated with high rates of morbidity and mortality [2].

                Zinc's pro-inflammatory impact is reliably proved in various in vitro as well as in vivo models. In separated human mononuclear cells and monocytes, zinc induces the expression of cytokines [11]. In pigs, zinc upregulates the release of inflammatory mediators by the induction the heat shock response [12]. And in a rat model of endotoxemia, zinc thus reduces the rates of apoptosis and mortality [13]. During the acute phase of sepsis, this pro-inflammatory capacity can even be deleterious due to complementary properties [14]. As CARS represents an overbalanced anti-inflammatory stage of sepsis, zinc's well-known pro-inflammatory potential could be an interesting tool to recover immune capability.

                To verify a rehabilitative effect of zinc on the immune system, this study analyses the impact of zinc on hemodynamics, pulmonary function, and cytokine liberation during a recurrent endotoxemia in a porcine model.


                Animal model

                The study was performed in adherence to the National Institutes of Health guidelines for the use of experimental animals observing the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education. Basically, we used the animal model for endotoxemia in domestic pigs as described by Klosterhalfen et al. [15]. Experiments were performed on female farm pigs (n = 10, Deutsche Landrasse) weighing 28–32 kg. The animals were randomised and divided into 2 groups (n = 5). After premedication (azaperon 3 mg/kg) and intubation (pentobarbital 6 mg/kg) anaesthesia was maintained by pentobarbital 0.1 mg/kg/min and ketamine 0.1 mg/kg/min. Arterial and venous catheters were placed in the right carotid artery and the right jugular vein. In addition, a measurement catheter of the Pulsion Cold System® (PULSION Medical systems, Munich, Germany) was introduced into the femoral artery in the right groin. After the completion of all surgical manipulations, hemodynamics and respiration were stabilised over a period of 60 min. The pigs were fully anaesthetised for the whole study period of 18 hours. Fluid balance was maintained by infusion of Ringer solution (3–6 ml/kg/h). Continuous measuring of the central venous pressure served as control.

                The first infusion of LPS defined hour 0 of the examination. For each application of LPS, 1.0 μg/kg E. coli endotoxin WO111:B4 (Difco Laboratories, Detroit, USA) was intravenously infused over 30 min. This LPS-infusion was repeated in each group at hours 5 and 12. To mimic an interim treatment during recurrent septicaemia, each group received an intravenous treatment (group I = saline, group II = zinc) at hour 10. As a result of former dose-finding studies [12, 15], 25 mg/kg zinc-bis-(DL-hydrogenaspartate) = 5 mg/kg elementary Zn2+ (Unizink®, Köhler Pharma, Alsbach-Hähnlein, Germany) were infused in group II. According to the suppliers instructions, the aspartate component in zinc-bis-(DL-hydrogenaspartate) has no established impact during endotoxemia. To avoid acute toxic effects, zinc as well as saline infusions were administered over 2 hours [12, 15].

                Hemodynamics and arterial oxygen saturation were continuously measured by arterial monitoring and pulse oxymetry (Oxyshuttle®, Criticaon, Hamburg, Germany). Due to former studies [12], blood samples for the measurement of respiratory parameters and cytokines (TNFα and IL-6) were registered at defined points of time (600, 615, 630, 645, 660, 720, 735, 750, 765, 780, 840, 930, 1020 min). The extravascular lung water (EVLW) and the arterial-venous intrapulmonary shunt were registered using the thermal dye dilution technique of the Pulsion Cold Z-021® system (PULSION medical systems, München, Germany) [16, 17]. In brief, the method uses ice-cold water and indocyanin green as indicators. Whereas cold distributes to the intra- and extravascular volumes, indocyanin green remains intravascular at 99.9%. Both indicators are injected into the right atrium, and concentration changes in time are recorded. Using the different dilution curves of both indicators, rates of the intrapulmonary shunt (Qs/Qt), the extravascular lung water (EVLW index (ml/kg) = intrathoracic thermal volume index – intrathoracic blood volume index), the cardiac output, and the systemic vessel resistance (SVRI = (systemic arterial pressure – central venous pressure) / (cardiac output / body mass)) can be calculated. The measuring points of the system corresponded with the blood gas samples.

                At the end of the study period (18 hours), all animals were killed by an intravenous infusion of potassium chloride. A necropsy followed with special regard to the macroscopic findings in the lungs and the liver.


                After removal, both lungs were weighed to indirectly measure the pulmonary endothelial leakage respectively the capillary leak syndrome. The width of the alveolar septums was defined as another indirect parameter of the interstitial edema. Therefore, multiple tissue samples from all pulmonary lobes were fixed in 10 % buffered formalin, embedded in paraffin, and sections of 4 μm were stained with hematoxylin and eosin. All measurements were quantified by morphometry at 500 different randomized locations per animal (Quantimed 500®, Leica Microsystems, Lübeck, Germany). In addition, the paracentral necrosis rate in the liver was quantified. After the histologic preparation of two representative samples of the right and left liver lobes, measurements were again analyzed by morphometry (Quantimed 500®, Leica Microsystems, Lübeck, Germany).

                Enzyme-linked immunosorbent assay (ELISA) of TNFα and IL-6

                The plasma concentrations of TNFα and IL-6 were measured by cross-reactive (human) ELISA kits according to the supplier's instructions (Biozol, Hamburg, Germany). All procedures were sandwich ELISAs. The molecules of interest were first bound by immobilized primary monoclonal antibodies, afterwards washed free and finally bound to polyclonal antibodies. The visualization followed by production of color after a peroxidase reaction. The color intensity was proportional to the amount of bound conjugation and thus, to the amount of present cytokine. The absorbance was measured using a Tito-Tek-Multiscan MK" ELISA reader (Flow ICN, Meckenheim, Germany) at 490 or 450 nm comparing the samples with pooled plasma from controls with increasing amounts of recombinant cytokine. The pooled plasma did not contain detectable concentrations of endogenous cytokines.


                For statistical analysis, the Statistical Package for Social Sciences (SPSS®) software was used. The significance of the pulmonary, hemodynamical, and biochemical parameters was tested by a corrected variance analysis. In case of significant differences, an independent t test followed. P-values < 0.05 were considered significant. All data was expressed as mean ± standard deviation (SD).


                Respiratory parameters

                After infusion of zinc (t = 600–720 min), the pigs of group II merely trended to an only partly improved pulmonary function compared to group I (saline) (Fig 1A–F). The arterial oxygen pressure was continuously measured higher reaching significance only at two times (t = 630 min and t = 1020 min). The venous oxygen pressure and the arterial oxygen saturation continuously showed higher values in the zinc-group, too. However, only once, the arterial oxygen saturation reached significance (t = 1020 min). The venous oxygen saturation and the arterial and venous carbon dioxide pressure demonstrated no significant differences. After the last infusion of LPS (t = 720 min), group II (zinc) showed steady measurements. In contrast, group I (saline) demonstrated a further slight decrease of the arterial oxygen pressure and the arterial oxygen saturation.
                Figure 1

                A-F Respiratory parameters: (A) arterial oxygen pressure, (B) venous oxygen pressure, (C) arterial carbon dioxide pressure, (D) venous carbon dioxide pressure, (E) arterial oxygen saturation, and (F) venous oxygen saturation; group I (saline) = triangle and group II (zinc) = circle; *p < 0,05; x-axis nonlinear

                Extravascular lung water (EVLW) and intrapulmonary shunt

                Analysing the thermal dye dilution data, EVLW and intrapulmonary shunt revealed no significant differences in both groups. In detail, the results were controversial. Group II (zinc) tended to result in higher rates of EVLW compared to group I (saline). In contrast, the intrapulmonary shunt consistently showed lower measurements (Fig 2A–B). However, all differences were not significant.
                Figure 2

                A-B Course of (A) extravascular lung water (EVLW, ml/kg body weight) and (B) intrapulmonary shunt (Qs/Qt, %); group I (saline) = triangle and group II (zinc) = circle; *p < 0.05; x-axis nonlinear


                In general, the hemodynamics revealed no impressive differences. Compared to group I (saline), the mean systemic arterial blood pressure (SAP) slightly decreased in group II during the infusion of zinc. Later on, both groups showed almost similar levels without significant differences (Fig 3A). Though zinc obviously induced no gageable effect, the systemic vessel resistance index (SVRI) initially showed lower measurements in group II (zinc). Compared to group I (saline), the difference reached significance at two times (615 and 630 min). Induced by a decline of SVRI in the saline group, both groups finally showed a parallel course (Fig. 3B). Measurements of the cardiac output revealed no remarkable differences at any time (Fig. 3C). Regarding all parameters, the last application of LPS (t = 720 min) induced no further changes in both groups.
                Figure 3

                A-C Hemodynamics: (A) mean systemic arterial pressure (SAP), (B) systemic vessel resistance index (SVRI), (C) cardiac output; group I (saline) = triangle and group II (zinc) = circle; *p < 0.05; x-axis nonlinear

                Inflammatory mediators TNFα and IL-6

                After zinc-infusion, TNFα in group II steadily increased compared to group I (saline). Boosted by the last LPS-infusion, this effect even reached significance but persisted only temporary. At the end, both groups showed almost similar results. In group I (saline), the level of TNFα showed no remarkable changes (Fig. 4A).
                Figure 4

                A, B Course of the cytokines TNFα (A) und IL-6 (B); group I (saline) = triangle and group II (zinc) = circle; *p < 0.05; x-axis nonlinear

                The expression of IL-6 was not influenced by zinc. However, the last application of LPS induced a drastic increase of IL-6 in group II (zinc). In parallel to TNFα, this increase temporary reached significance compared to group I (saline). Later on, IL-6 increased to a smaller amount in group I (saline) as well. Caused by a parallel decrease in group II (zinc), both groups finally revealed similar results (Fig. 4B).

                The significant increases of TNFα and IL-6 did not correlate with the measured differences in hemodynamics or pulmonary parameters.


                With an increased alveolar width (group I: 11.3 μm, group II: 12.2 μm) and an elevated rate of the paracentral liver necrosis (group I: 4.3 %, group II: 7.9 %), both groups showed the typical signs of a septic organ damage. Both measurements revealed a broad range and the differences were not significant. The weight of the lungs (group I: 320.8 g, group II: 338.6 g) was measured higher in group II (zinc). Again, the results included high standard errors and did not reach significance.


                Administered as a prophylaxis, zinc's pro-inflammatory impact protects from septic cellular damages in vivo as well as in vitro [1113, 1820]. In a porcine model of acute endotoxemia, this pro-inflammatory effect even leads to deleterious results [14]. Thus, zinc could be predestined to restore the depressed immune capability during CARS. To our knowledge, the application of zinc during a recurrent endotoxemia in vivo is not yet described in literature.

                To mimic a prolonged and repeated endotoxemia comparable to the human CARS-syndrome, we used the porcine model introduced by Klosterhalfen et al. [15]. The chronic form of endotoxemia was induced by recurrent LPS-infusions. In contrast to high dosage or bolus regimens, this application form more reliably imitates the clinical course of human sepsis [15]. Firstly, the typical septic organ damages found during necropsy confirmed the usability of this model. In both groups, the alveolar width and the rate of the paracentral liver necrosis were increased. Nevertheless, we found no significant differences comparing both study groups. Obviously, the application of zinc did not protect from cellular damages in our setting. Due to former dose finding studies in recurrent endotoxemia, this should rather not be a question of dosage [12, 15]. However, kinetics in recurrent and acute endotoxemia are different [12, 14, 15, 18], and zinc's optimal application rate still needs to be defined. In our opinion, the lack of impact more likely could derive from a too short registration time. Possibly, observations limited to 18 hours are insufficient to draw conclusions about the late state of LPS-induced endotoxemia.

                In general, our data confirm, that the application of zinc in between a recurrent endotoxemia is well tolerated. With an almost parallel course, hemodynamic changes were rare in both groups. Besides a slight and temporary decrease of the systemic arterial pressure in the zinc-group, we did not find a relevant hemodynamic depression neither induced by zinc nor by LPS. These results contrast the deleterious pro-inflammatory impact of zinc during the acute phase of sepsis in-vivo, where complementing effects severely degraded hemodynamics and lead to an early death after 3 hours [14]. However, we observed no positive effect on the hemodynamic variables as well. Thus, the application of zinc in our model of recurrent endotoxemia in vivo is feasible but without measurable beneficial effects in hemodynamics.

                The respiratory parameters reproduced the hemodynamic findings, as remarkable differences in both groups were very rare. Again, the application of zinc was well tolerated. In detail, the animals of group II (zinc) even tended to a slightly improved pulmonary function. However, significant differences of clinical relevance were missing. In our setting, zinc apparently not achieved its protective effect on pulmonary function and cell integrity reported on various studies [1820]. Besides a longer observation time, this could be clarified by measuring the heat shock response (HSR) representing a possible pathway [13, 18, 2023]. Regarding extravascular lung water (EVLW) and intrapulmonary shunt, our results were even conflicting. In conclusion, they could prove neither any protective nor any negative impact associated to zinc. Referring to their prognostic value, these parameters currently rank even higher than simple reflections of the gas exchange [24]. Thus, our findings on this field underline the lack of a clinically relevant pulmonary protection supposed above.

                Regarding the liberation of the cytokines, our results remain disappointing. The changes of TNFα and IL-6 after the last LPS-application in the zinc-group revealed an increased liberation of cytokines, but the effect remained short-termed. Significant differences were only sporadically found. Except for a questionable temporary boosting, this phenomenon cannot represent a reliable reactivation of the pro-inflammatory response. Obviously, the inductive potential of zinc on the expression of pro-inflammatory cytokines [11, 12, 14, 19, 25] has no long-lasting impact in our model of recurrent endotoxemia. As the infusion of LPS in the saline-group additionally induced no measurable decrease in cytokine liberation, this may be again a question of observation time.


                In conclusion, the application of zinc in our experimental setting of recurrent endotoxemia is feasible and induces no harmful effects. However, we could not derive any protective or rehabilitative effect of clinical relevance on respiration, hemodynamics, or cytokine liberation. Though the rate of septic cellular damages in this animal setting is quite similar to those seen in patients with chronic sepsis, it cannot completely reflect the situation in humans. Time course, dosages, and perhaps even the LPS-model must be challenged [26]. As multiple in vitro and in vivo studies as well as clinical trials point out that depressed plasma levels of pro-inflammatory cytokines are accompanied by high rates of lethality [68, 2730], the restoration of the immune capability remains a challenging therapeutic aim during prolonged endotoxemia. Despite our deflating results, further pre-clinical studies including long-term observations and measurements of the heat shock response have to be established to define zinc's role in this context.


                Authors’ Affiliations

                Department of Surgery, Technical University of Aachen
                Institute of Pathology, Technical University of Aachen
                Joint Institute for Surgical Research, Leninskie Gory


                1. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996, 24:1125–28.View ArticlePubMed
                2. Oberholzer A, Oberholzer C, Moldawer LL: Sepsis syndromes: Understanding the role of innate and acquired immunity. Shock 2001, 16:83–96.View ArticlePubMed
                3. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993, 269:1829–35.View ArticlePubMed
                4. Doughty L, Kaplan S, Carcillo J: The IL-10 response in pediatric sepsis and organ failure. Crit Care Med 1996, 24:1137–43.View ArticlePubMed
                5. Platzer C, Meisel CH, Vogt K, Patzer M, Volk HD: Upregulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int Immunol 1995, 7:517–23.View ArticlePubMed
                6. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenbeele P, Delvaux A, Fiers W, Goldman M, Velu T: Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993, 177:547–50.View ArticlePubMed
                7. Howard M, Muchamel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993, 177:1205–8.View ArticlePubMed
                8. Gomez Jimenez J, Martin MC, Sauri R, Segura RM, Esteban F, Ruiz JC, Nuvials X, Boveda JL, Peracaula R, Salgado A: Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 1995, 171:472–5.PubMed
                9. Junger WG, Hoyt DB, Liu FC, Loomis WH, Coimbra R: Immunosuppression after endotoxin shock: the results of multiple anti-inflammatory factors. J Trauma 1996, 40:702–9.View ArticlePubMed
                10. Muchamel T, Menon S, Pisacane P, Howard MC, Cockayne DA: IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol 1997, 158:2898–903.
                11. Driessen C, Hirv K, Rink L, Kirchner H: Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res 1994, 13:15–20.PubMed
                12. Klosterhalfen B, Toens C, Hauptmann S, Tietze L, Offner FA, Kuepper W, Kirkpatrick CJ: Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. Biochem Pharmacol 1996, 52:1201–10.View ArticlePubMed
                13. Klosterhalfen B, Hauptmann S, Offner FA, Amo-Takyi B, Toens C, Winkeltau G, Affify M, Kuepper W, Kirkpatrick CJ, Mittermayer C: Induction of heat shock protein 70 by zinc-bis-(DL-hydrogenaspartate) reduces cytokine liberation, apoptosis, and mortality rate in a rat model of LD100 endotoxemia. Shock 1997, 7:254–62.View ArticlePubMed
                14. Krones CJ, Klosterhalfen B, Fackeldey V, Junge K, Rosch R, Schwab R, Stumpf M, Klinge U, Schumpelick V: Deleterious effect of zinc in a pig model of acute endotoxemia. J Invest Surg 2004, 17:249–56.View ArticlePubMed
                15. Klosterhalfen B, Hörstmann-Jungemann K, Vogel P, Dufhues G, Simon B, Kalff G, Kirkpatrick CJ, Mittermayer C, Heinrich PC: Hemodynamic variables and plasma levels of PGI2, TxA2 and IL-6 in a porcine model of recurrent endotoxemia. Circ Shock 1991, 35:237–44.PubMed
                16. Lewis FR, Elings VB: Bedside measurement of lung water. J Surg Res 1979, 27:250–61.View ArticlePubMed
                17. Pfeiffer UJ, Backus G, Blümel G: A fiberoptics based system for integrated monitoring of cardiac output, intravascular blood volume, extravascular lung water, O2-saturation, and a-v differences. Practical applications of fiberoptics in critical care monitoring (Edited by: Lewis FR, Pfeiffer UJ). Berlin: Springer 1990, 114–225.
                18. Krones CJ, Klosterhalfen B, Butz N, Hoelzl F, Junge K, Stumpf M, Peiper C, Klinge U, Schumpelick V: Effect of zinc pretreatment on pulmonary endothelial cells in vitro and pulmonary function in a porcine model of endotoxemia. J Surg Res 2005,123(2):251–256.View ArticlePubMed
                19. Unoshima M, Nishizono A, Takita-Sonoda Y, Iwasaka H, Noguchi T: Effects of zinc acetate on splenocytes of endotoxemic mice: enhanced immune response, reduced apoptosis, and increased expression of heat shock protein 70. J Lab Clin Med 2001, 137:28–37.View ArticlePubMed
                20. Hennig B, Wang Y, Ramasamy S, McClain CJ: Zinc protects against tumor necrosis factor-induced disruption of porcine endothelial cell monolayer integrity. J Nutr 1993, 123:1003–9.PubMed
                21. Villar J, Ribeiro SP, Mullen BM, Kuliszewski M, Post M, Slutsky AS: Induction of heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury. Crit Care Med 1994, 22:914–22.View ArticlePubMed
                22. Wong HR, Ryan M, Menendez IY, Deneberg A, Wispe JR.: Heat shock protein induction protects human respiratory epithelium against nitric oxide-mediated cytotoxicity. Shock 1997, 8:213–8.View ArticlePubMed
                23. Cheng Y, Liu Y, Liang J: Zinc is a potent heat shock protein inducer during liver cold preservation of rats. Chin Med J (Engl) 2002, 115:1777–9.
                24. Sakka SG, Klein M, Reinhart K, Meier-Hellmann A: Prognostic value of extravascular lung water in critically ill patients. Chest 2002, 122:2080–6.View ArticlePubMed
                25. Klosterhalfen B, Hauptmann S, Tietze L, Toens C, Winkeltau G, Kuepper W, Kirkpatrick CJ: The influence of heat shock protein 70 induction on hemodynamic variables in a porcine model of recurrent endotoxemia. Shock 1997, 7:358–63.View ArticlePubMed
                26. Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. Cecal ligation and puncture. Shock 2000, 13:110–6.View ArticlePubMed
                27. Florquin S, Amraoui Z, Abramowicz D, Goldman M: Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol 1994, 153:2618–23.PubMed
                28. Arai T, Hiromatsu K, Nishimura H, Kimura Y, Kobayashi N, Ishida H, Nimura Y, Yoshikai Y: Endogenous interleukin 10 prevents apoptosis in macrophages during salmonella infection. Biochem Biophys Res Commun 1995, 213:600–7.View ArticlePubMed
                29. Drazan KE, Wu L, Bullington D, Shaked A: Viral IL-10 gene therapy inhibits TNF-alpha and IL-1 beta, not Il-6, in the endotoxemic mouse. J Pediatr Surg 1996, 31:411–5.View ArticlePubMed
                30. Cabioglu N, Bilgic S, Deniz G, Aktas E, Seyhun Y, Turna A, Gunay K, Esen F: Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis. Arch Surg 2002, 137:1037–43.View ArticlePubMed
                31. Pre-publication history

                  1. The pre-publication history for this paper can be accessed here:http://​www.​biomedcentral.​com/​1471-2482/​5/​22/​prepub


                © Krones et al. 2005

                This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.